Tuftsin, A Natural Activator of Phagocyte Cells: An Overview a
1983; Wiley; Volume: 419; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1983.tb37086.x
ISSN1749-6632
Autores Tópico(s)Inhalation and Respiratory Drug Delivery
ResumoAnnals of the New York Academy of SciencesVolume 419, Issue 1 p. 1-11 Tuftsin, A Natural Activator of Phagocyte Cells: An Overviewa VICTOR A. NAJJAR, VICTOR A. NAJJAR Division of Protein Chemistry Tufts University School of Medicine Boston, Massachusetts 02111Search for more papers by this author VICTOR A. NAJJAR, VICTOR A. NAJJAR Division of Protein Chemistry Tufts University School of Medicine Boston, Massachusetts 02111Search for more papers by this author First published: December 1983 https://doi.org/10.1111/j.1749-6632.1983.tb37086.xCitations: 84 a This work was supported by the Public Health Service Grant 5RO1-A 109116, the March of Dimes Birth Defects Foundation Grant 1–556 and by the American Cancer Society, Inc. Grant R.D.P. 32A. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 NAJJAR, V. A. & J. FISHER. 1955. Mechanism of antibody-antigen reaction. Science 122: 1272–1273. 10.1126/science.122.3183.1272-a CASPubMedWeb of Science®Google Scholar 2 NAJJAR, V. A. & J. FISHER. 1956. The mechanism of antibody-antigen reaction. Biochem. Biophys. Acta 20: 158–169. 10.1016/0006-3002(56)90274-8 CASPubMedWeb of Science®Google Scholar 3 NAJJAR, V. A. 1963. Some aspects of antibody-antigen reactions and theoretical considerations of the immunologic response. Phys. Rev. 43: 243–262. 10.1152/physrev.1963.43.2.243 CASPubMedWeb of Science®Google Scholar 4 HARSHMAN, S., J. P. ROBINSON & V. A. NAJJAR. 1963. The mechanism of antibody-antigen interaction and the theory of sub-complementarity between the reactive site of antibody and antigen. Ann. N.Y. Acad. Sci. 103: 688–714. 10.1111/j.1749-6632.1963.tb53727.x CASPubMedWeb of Science®Google Scholar 5 NAJJAR, V. A. & J. P. ROBINSON. 1959. A unified concept in immunologic reactions allergic states. In Immunity and Virus Infection. V. A. Najjar, Ed. John Wiley & Sons, Inc. New York . pp. 71–91. Google Scholar 6 SCHRATER, A. F., E. A. GOIDL, G. J. THORBECKE & G. W. SISKIND. 1979. Production of auto-idiotypic antibody during the normal immune response to TNP-FICOLL. J. Exp. Med. 150: 808–817. 10.1084/jem.150.4.808 CASPubMedWeb of Science®Google Scholar 7 JERNE, N. K. 1974. Towards a network of the immune system. Ann. Immunol. (Paris) 125: 373–389. Google Scholar 8 NAJJAR, V. A., J. P. ROBINSON, A. R. LAWTON & B. V. FIDALOO. 1967. The physiological role of the lymphoid system. I: An extension of the mechanism of antibody-antigen reaction. Johns Hopkins Med. J. 120: 63–77. CASPubMedWeb of Science®Google Scholar 9 NAJJAR, V. A. & M. GRIFFITH. 1964. The heterogeneity of the antibody site to a given antigenic determinant. Biochem. Biophys. Res. Commun. 16: 472–477. 10.1016/0006-291X(64)90378-X CASPubMedWeb of Science®Google Scholar 10 FIDALGO, B. V., Y. KATAYAMA & V. A. NAJJAR. 1967. The physiological r ole of the lymphoid system. V. The binding autologous (Erythrophilic) γ-globulin to human red blood cells. Biochemistry 6: 3378–3385. 10.1021/bi00863a007 CASPubMedWeb of Science®Google Scholar 11 FIDALGO, B. V., V. A. NAJJAR, C. F. ZUKOSKI & Y. KATAYAMA. 1967. The physiological role of the lymphoid system. II. Erythrophylic γ-globulin and the survival of the erythrocyte. Proc. Natl. Acad. Sci. USA 57: 665–672. 10.1073/pnas.57.3.665 CASWeb of Science®Google Scholar 12 CONSTANTOPOULOS, A. & V. A. NAJJAR. 1974. The physiological role of the lymphoid system. The binding of autologous thrombophilic γ-globulin to human platelets. Eur. J. Biochem. 41: 135–138. 10.1111/j.1432-1033.1974.tb03253.x CASPubMedWeb of Science®Google Scholar 13 SANDBJERG-HANSEN, M. & N. U. BANG. 1979. Plasma protein regulation. Mol. Cell. Biochem. 24: 143–158. PubMedWeb of Science®Google Scholar 14 FIDALGO, B. V. & V. A. NAJJAR. 1967. The physiological role of the lymphoid system. III. Leukophilic γ-globulin and the phagocytic activity of the polymorphonuclear leucocyte. Proc. Natl. Acad. Sci. USA 57: 957–964. 10.1073/pnas.57.4.957 CASPubMedWeb of Science®Google Scholar 15 FIDALGO, B. V. & V. A. NAJJAR. 1967. The physiological role of the lymphoid system. VI. The stimulatory effect of leucophilic γ-globulin (Leucokinin) on the phagocytic activity of human polymorphonuclear leucocyte. Biochemistry 6: 3386–3392. CASPubMedWeb of Science®Google Scholar 16 SARAVIA, N. G., S. DERRYBERRY & J. P. ROBINSON. 1978. The association of serum proteins with peripheral blood cells at low ionic strength: Ultrastructural examination. Mol. Cell. Biochem. 20: 167–172. 10.1007/BF00243763 CASPubMedWeb of Science®Google Scholar 17 CONSTANTOPOULOS, A. & V. A. NAJJAR. 1972. Tuftsin, a natural and general phagocytosis-stimulating peptide affecting macrophages and polymorphonuclear granulocytes. Cytobios 6: 97–100. CASWeb of Science®Google Scholar 18 NISHIOKA, K., A. CONSTANTOPOULOS, P. S. SATOH, W. M. MITCHELL & V. A. NAJJAR. 1973. Characteristics and isolation of the phagocytosis-stimulating peptide, tuftsin. Biochim. Biophys. Acta 310: 217–229. 10.1016/0005-2795(73)90024-X CASPubMedWeb of Science®Google Scholar 19 NAJJAR, V. A. 1974. The physiological role of γ-globulin. In Advances in Enzymology. D. Alan Meister, Ed. 41: 129–178. John Wiley & Sons, Inc. New York . 10.1002/9780470122860.ch4 Web of Science®Google Scholar 20 NISHIOKA, K., P. S. SATOH, A. CONSTANTOPOULOS & V. A. NAJJAR. 1973. The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. Biochim. Biophys. Acta 310: 230–237. 10.1016/0005-2795(73)90025-1 CASPubMedWeb of Science®Google Scholar 21 NAJJAR, V. A. & K. NISHIOKA. 1970. Tuftsin—a physiological phagocytosis-stimulating peptide. Nature 228: 672–673. 10.1038/228672a0 CASPubMedWeb of Science®Google Scholar 22 NAJJAR, V. A. 1976. The physiological role of membrane γ-globulin interaction. In Biological Membranes. D. Chapman & D. F. H. Wallach, Eds. 5: 191–240. Academic Press, Inc., New York . Google Scholar 23 EDELMAN, G. M., B. A. CUNNINGHAM, W. E. GALL, P. D. GOTTLIEB, U. RUTISHAUSER & M. J. WAXDAL. 1969. The covalent structure of an entire γ-globulin immunoglobulin molecule. Proc. Natl. Acad. Sci. USA 63: 78–85. 10.1073/pnas.63.1.78 CASPubMedWeb of Science®Google Scholar 24 NAJJAR, V. A. 1980. Biological and biochemical characteristics of the tetrapeptide tuftsin, Thr-Lys-Pro-Arg. In Macrophages and Lymphocytes, Part A. M. R. Escobar & H. Friedman, Eds. Plenum Publishing Corp. New York . 10.1007/978-1-4684-3593-1_12 Google Scholar 25 NAJJAR, V. A. 1980. Biochemistry and physiology of tuftsin Thr-Lys-Pro-Arg. In The Reticuloendothelial System. A. J. Sbarra & R. Strauss, Eds. Vol. 2. Plenum Publishing Corp. New York . pp. 45–71. Google Scholar 26 NAJJAR, V. A. 1975. Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsin. J. Pediatr. 87: 1121–1124. 10.1016/S0022-3476(75)80125-9 CASPubMedWeb of Science®Google Scholar 27 NAJJAR, V. A. & A. CONSTANTOPOULOS. 1972. A new phagocytosis-stimulating tetrapeptide hormone tuftsin and its role in disease. J. Reticuloendothel. Soc. 12: 197–215. CASPubMedWeb of Science®Google Scholar 28 NAJJAR, V. A. 1979. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis. Klin. Wochenschr. 57: 751–756. 10.1007/BF01478032 PubMedWeb of Science®Google Scholar 29 NAJJAR, V. A. 1982. Cytophilic γ-globulin and tuftsin. Surv. Immunol. Res. 1: 9–16. CASPubMedGoogle Scholar 30 INADA, K., N. NEMOTO, A. NISHIJIMA, S. WADA, M. HIRATA & M. YOSHIDA. 1977. A case of suspected tuftsin deficiency. In Phagocytosis: Its Physiology and Pathology. Y. Kokobun & N. Kobayashi, Eds. University Park Press. Baltimore , pp. 101–108. Google Scholar 31 MORGAN, E. L., T. E. HUGLI & W. O. WEIGLE. 1982. Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1. Proc. Natl. Acad. Sci. USA 79: 5388–5391. 10.1073/pnas.79.17.5388 CASPubMedWeb of Science®Google Scholar 32 E. A. KABAT, T. T. WU & H. BILOFSKY, Eds. Sequences of immunoglobulin chains. U.S. Department of Health, Education and Welfare. National Institutes of Health Publication No. 80 2008. Google Scholar 33 LUKAS, T. J., H. MUNOZ & B. W. ERICKSON. 1981. Inhibition of C1-mediated immune hemolysis of monomeric and dimeric peptides from the second constant domain of human immunoglobulin C. J. Immunol. 127: 2555–2560. CASPubMedWeb of Science®Google Scholar 34 NISHIOKA, K., A. A. AMOSCATO & G. F. BABCOCK. 1981. Minireview. Tuftsin: A hormone-like tetrapeptide with antimicrobial and antitumor activities. Life Sciences 28(10): 1081–1090. 10.1016/0024-3205(81)90684-6 CASPubMedWeb of Science®Google Scholar 35 RAUNER, R. A., J. J. SCHMIDT & V. A. NAJJAR. 1976. Proline endopeptidase and exopeptidase activity in polymorphonuclear granulocytes. Mol. Cell. Biochem. 10: 77–80. 10.1007/BF01742201 CASPubMedWeb of Science®Google Scholar 36 SPIRER, Z., V. ZAKUTH, A. GOLANDER, N. BOGAIR & M. FRIDKIN. 1975. The effect of tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes. J. Clin. Invest. 55: 198–200. 10.1172/JCI107912 CASPubMedWeb of Science®Google Scholar 37 FRIDKIN, M., Y. STABINSKY, V. ZAKUTH & Z. SPIRER. 1976. Synthesis, structure-activity relationships and radioimmunoassay of tuftsin. In Peptides. A. Loffet, Ed. Editions de l'Université de Bruxelle, Belgique . pp. 541–549. Google Scholar 38 FRIDKIN, M., Y. STABINSKY, V. ZAKUTH & Z. SPIRER. 1977. Tuftsin and some analogs. Synthesis and interaction with human polymorphonuclear leukocytes. Biochim. Biophys. Acta 496: 203–211. 10.1016/0304-4165(77)90129-5 CASPubMedWeb of Science®Google Scholar 39 NAJJAR, V. A., M. K. CHAUDHURI, D. KONOPIŃSKA, B. D. BECK, P. P. LAYNE & L. LINEHAN. 1981. Tuftsin (Thr-Lys-Pro-Arg), a physiological activator of phagocytic cells: A possible role in cancer suppression and therapy. In Augmenting Agents in Cancer Therapy. E. M. Hersh, M. A. Chirigos & M. J. Mastrangelo, Eds. Raven Press. New York . pp. 459–478. Google Scholar 40 NAJJAR, V. A., D. KONOPIŃSKA, M. K. CHAUDHURI, D. E. SCHMIDT & L. LINEHAN. 1981. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity. Mol. Cell. Biochem. 41: 3–12. 10.1007/BF00225292 CASPubMedWeb of Science®Google Scholar 41 ADETUGBO, K., C. MILSTEIN & D. S. SECHER. 1977. Molecular analysis of spontaneous somatic mutants. Nature (London) 265: 299. 10.1038/265299a0 CASPubMedWeb of Science®Google Scholar 42 OROSZLAN, S., L. E. HENDERSON, J. R. STEPHENSON, T. D. COPELAND, C. W. LONG, J. N. IHLE & R. V. GILDEN. 1978. Amino- and carboxyl-terminal amino acid sequences of murine leukemia virus gag gene coded proteins. Proc. Natl. Acad. Sci. USA 75: 1404–1408. 10.1073/pnas.75.3.1404 CASPubMedWeb of Science®Google Scholar 43 LUFTIG, R. B., Y. YOSHINAKA & S. OROSZLAN. 1977. Sequence relationships between Rauscher leukemia virus P65–70 (gag gene product) and tuftsin as monitored by the P65–70 proteolytic factor. J. Cell Biol. 75: 397. Google Scholar 44 SUK, W. A. & C. W. LONG. 1979. Induction of endogenous murine retrovirus by the tetrapeptides tuftsin and kentsin. Am. Soc. Microbiol. 257: (Abstract S105). Google Scholar 45 GETHING, M. J., J. BYE, J. SKEHEL & M. WATERFIELD. 1980. Cloning and DNA sequence of double-stranded complex of haemagglutinin chains from H2 and H3 strains elucidates antigen shift and drift in human influenza virus. Nature 287: 301–306. 10.1038/287301a0 CASPubMedWeb of Science®Google Scholar 46 BLUNDELL, T. L. & R. E. HUMBEL. 1980. Hormone families: Pancreatic hormones and homologous growth factors. Nature 287: 781–787. 10.1038/287781a0 CASPubMedWeb of Science®Google Scholar 47 GATES, R. J. & N. LAZARUS. 1977. The ability of pancreatic polypeptides (APP & BPP) to return to normal the hyperglycemia hyperinsulinanemia and weight gain of New Zealand obese mice. Hormone Res. 8: 189–202. 10.1159/000178800 CASPubMedWeb of Science®Google Scholar 48 KONOPIŃSKA, D., E. NAWROCKA, I. Z. SIEMION & S. SLOPEK. 1978. Tuftsin and its analogues. III. The modification of basic amino acid residues in the peptide chain. Arch. Immunol. Ther. Exp. 26: 151–157. Google Scholar 49 HISATSUNE, K., K. KOBAYASHI, S. NOZAKI & I. MURAMATSU. 1978. Phagocytosis-stimulating activity of tuftsin analogs. Microbiol. Immunol. 22: 581–584. 10.1111/j.1348-0421.1978.tb00407.x CASPubMedWeb of Science®Google Scholar 50 VERETENNIKOVA, N. I., YU I. INDULEN, G. V. NIKIFOROVICH, O. S. PAPSUYEVICH & G. I. CHIPENS. 1978. Synthesis and properties of phagocytosis-stimulating factor, tuftsin and its analogues. 11th Int. S. Chem. Nat. Vol. 1: 263–266. CASGoogle Scholar 51 VERETENNIKOVA, N. I., G. I. CHIPENS, G. V. NIKIFOROVICH & Y. R. BETINSH. 1979. Rigin, another phagocytosis-stimulating tetrapeptide isolated from human IgG. Confirmations of a hypothesis. Int. J. Pep. Protein Res. 17(4): 430–435. 10.1111/j.1399-3011.1981.tb02011.x Web of Science®Google Scholar 52 KONOPIŃSKA, D., I. Z. SIEMION, ST. SZYMANIEC, S. SLOPEK. 1978. Tuftsin and its analogs. Part IV. Synthesis of new tuftsin analogs based on simulation of genetic mutations. Pol. J. Chem. 52: 573–580. Web of Science®Google Scholar 53 KONOPIŃSKA, D., I. Z. SIEMION, E. BAROS-STULIOLOWA. 1978. Tuftsin and its analogs. Part VI. Biological effect of the substitution of the consecutive residues in the peptide chain by leucine. Pol. J. Chem. 52: 2255–2260. Web of Science®Google Scholar 54 KONOPIŃSKA, D., I. Z. SIEMION, ST. SZYMANIEC & S. SLOPEK. 1979. Tuftsin and its analogs. Part VII. Experimental proof of the hypothesis on functional conservatism in coding of tuftsin sequence. Pol. J. Chem. 53: 343–351. Web of Science®Google Scholar 55 MARTINEZ, J., F. WINTERNITZ & J. VINDEL. 1977. Nouvelles synthèses et propriètès de la tuftsine. Eur. J. Med. Chem. Chim. Ther. 12: 511–516. CASWeb of Science®Google Scholar 56 VICAR, J., V. GUT, I. FRIC & K. BLAHA. 1976. Synthesis and properties of tuftsin, l-threonyl-l-lysyl-l-prolyl-l-arginine. Collection Czechoslav. Chem. Commun. 41: 3467–3473. 10.1135/cccc19763467 CASWeb of Science®Google Scholar 57 YAJIMA, H., H. OGAWA, H. WATANABE, N. FUJI, M. KUROBE & S. MIYAMOTO. 1975. Studies on peptides. XLVIII. Application of the trifluromethanesulphonic acid procedure to the synthesis of tuftsin. Chem. Pharm. Bull. 23: 371–374. CASWeb of Science®Google Scholar 58 NAJJAR, V. A. & J. J. SCHMIDT. 1980. The chemistry and biology of tuftsin. In Lymphokin Reports. E. Pick, Ed. Vol. 1: 157–179. Academic Press. New York . Google Scholar 59 TZEHOVAL, E., S. SEGAL, Y. STABINSKY, M. FRIDKIN, Z. SPIRER & M. FELDMAN. 1978. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macro-phages: General implication to activation of programmed cells. Proc. Natl. Acad. Sci. USA 75: 3400–3404. 10.1073/pnas.75.7.3400 CASPubMedWeb of Science®Google Scholar 60 FLORENTIN, I., M. BRULEY-ROSSET, N. KIGER, J. L. IMBACH, F. WINTERNITZ & G. MATHÉ. 1978. In vivo immunostimulation by tuftsin. Cancer Immunol. Immunother. 5: 211–216. 10.1007/BF00199631 CASWeb of Science®Google Scholar 61 NISHIOKA, K. 1979. Anti-tumour effect of the physiological tetrapeptide tuftsin. Br. J. Cancer 39(3): 342–345. 10.1038/bjc.1979.59 CASPubMedWeb of Science®Google Scholar 62 NAJJAR, V. A. & L. LINEMAN. 1982. Tumoricidal activity of tuftsin. Proc. XIII Int. Cancer Congr. pp. 314. Google Scholar 63 FRIDKIN, M. & P. GOTTLIEB. 1981. Tuftsin, Thr-Lys-Pro-Arg. Mol. Cell. Biochem. 41: 73–97. 10.1007/BF00225299 CASPubMedWeb of Science®Google Scholar 64 CATANE, R., S. SCHLANGER, P. GOTTLIEB, J. HALPERN, A. J. TREVES, Z. FUKS & M. FRIDKIN. 1981. Toxicology and antitumor activity of tuftsin in mice. Proc. Am. Assoc. Cancer Res. & Am. Soc. Clin. Oncol. 22: 371. Web of Science®Google Scholar 65 BRULEY-ROSSET, M., T. HERCEND, J. MARTINEZ, H. RAPPAPORT & G. MATHÉ. 1981. Prevention of spontaneous tumors of aged mice by immunopharmacologic manipulation: Study of immune antitumor mechanisms. JNCI 66(6): 1113–1119. CASPubMedWeb of Science®Google Scholar Citing Literature Volume419, Issue1Antineoplastic, Immunogenic and Other Effects of the Tetrapeptide Tuftsin: A Natural Macrophage ActivatorDecember 1983Pages 1-11 ReferencesRelatedInformation
Referência(s)